ArticleMolecular cancer therapeutics2022

Novel Group C Oncolytic Adenoviruses Carrying a miRNA Inhibitor Demonstrate Enhanced Oncolytic Activity In Vitro and In Vivo.

Johannes Doerner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.